Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status has been updated to 'No longer looking for participants', indicating recruitment is closed. The page also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention header formatting from 'Intervention / Treatment' to 'Intervention/Treatment', along with a revision note showing v3.6.0.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page revision stamp changed from v3.5.4 to v3.5.5, indicating a new version of the page content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe Publications section now includes the Lancet Neurology 2021 ADAPT trial citation, and the related Erratum entry has been removed, clarifying the study’s bibliographic sources. This update aligns the record with current references and reflects the updated revision versioning for this entry.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3, signaling a new version of the page content. This change does not modify study details or user-facing information.SummaryDifference0.0%

- Check67 days agoChange DetectedUpdated the Publications entry to include the Lancet Neurology ADAPT study citation with an erratum and revision v3.5.2; the older v3.5.0 entry was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedNapoli, Italy (80131) site name changed to Naples, Italy (80131). Expanded Access note 'Available outside the clinical trial' added and page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.